These and many other questions would require some research. My only worry is that we don’t have the source of the data, and so can’t be certain of its reliability, but the visualization is nice fun to look at. Now watch the video and keep an eye on a few of the smaller occasions...
Approximately 20–40% of ITP patients do not have detectable anti-GP autoantibodies, suggesting alternative mechanisms of platelet destruction. Many studies have demonstrated that CD8+cytotoxic T lymphocytes (CTLs) from peripheral blood or spleen of ITP patients can directly lyse platelets or induce pl...
What are the issues surrounding the decision to proceed with transplantation in this scenario? There are few modern cohorts of patients with prior IFDs undergoing HSCT (Table 1). In this review, we aim to critically evaluate the many host-, procedure- (SCT), fungal-, and antifungal treatment...